iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.8267
-0.0421 (-4.85%)
At close: Oct 13, 2025, 4:00 PM EDT
0.8177
-0.0090 (-1.09%)
After-hours: Oct 13, 2025, 6:57 PM EDT
iSpecimen Market Cap
iSpecimen has a market cap or net worth of $4.58 million as of October 13, 2025. Its market cap has increased by 35.26% in one year.
Market Cap
4.58M
Enterprise Value
4.28M
1-Year Change
35.26%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on June 17, 2021, iSpecimen's market cap has decreased from $50.15M to $4.58M, a decrease of -90.87%. That is a compound annual growth rate of -42.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 4.81M | 88.30% |
| Dec 31, 2024 | 2.56M | -43.75% |
| Dec 29, 2023 | 4.54M | -62.95% |
| Dec 30, 2022 | 12.26M | -81.98% |
| Dec 31, 2021 | 68.07M | 35.75% |
| Jun 17, 2021 | 50.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |